4//SEC Filing
PASCALE ADAM 4
Accession 0001613377-19-000001
CIK 0000946644other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 1:40 PM ET
Size
9.0 KB
Accession
0001613377-19-000001
Insider Transaction Report
Form 4
Pascale Adam
Chief Accounting Officer
Transactions
- Exercise of In-Money
Series B Convertible Preferred Stock
2019-02-27+10→ 10 total - Exercise of In-Money
Warrants
2019-02-27+50,000→ 50,000 total - Exercise of In-Money
Subr Rights(to buy)
2019-02-27$1000.00/sh+10$10,000→ 0 totalExercise: $1000.00From: 2019-02-14Exp: 2019-03-05→ Pref Stk/Warrants
Footnotes (3)
- [F1]Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering.
- [F2]Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering.
- [F3]Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants.
Documents
Issuer
HEMISPHERX BIOPHARMA INC
CIK 0000946644
Entity typeother
Related Parties
1- filerCIK 0001613377
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 1:40 PM ET
- Size
- 9.0 KB